The report “North America Intrauterine Contraceptive Devices Market (IUD/IUCD) (Hormonal IUCS, Copper IUCD) – Trends and Forecasts to 2019” is expected to reach a value of $789.8 million by 2019, estimated to grow at a CAGR of 0.3% from 2014 to 2019.
Browse through the TOC of “North America Intrauterine Contraceptive Devices Market (IUD/IUCD) (Hormonal IUCS, Copper IUCD) – Trends and Forecasts to 2019” for an analysis of industry trends and segments, with the help of various tables and figures.
Early buyers will receive 10% customization on reports.
Intrauterine device (IUCD) is a small contraceptive device that is inserted into the uterus to prevent pregnancy. IUCDs are available in two types-copper and hormonal IUCD. The hormonal IUCD contains progesterone, which is a synthetic version of the naturally occurring hormone progesterone. Both these types are very effective methods of contraception and can stay in place for an average of at least five years.
The major drivers behind the growing intrauterine contraceptive devices market in North America include increasing rate of unplanned pregnancies, effective contraceptive method, and less side effects when compared to other contraceptive methods. In the U.S, 82.0% of adolescent pregnancies are unplanned, accounting for one-fifth of all unintended pregnancies. The users, especially adolescents trust the intrauterine devices market, as it is extremely reliable and effective. As a result, long-acting reversible contraception (LARC) methods, such as intrauterine contraceptive devices are adopted on a large scale.
The U.S. contribution to the intrauterine contraceptive devices market in North America was 93%, as of 2014. In the U.S, under the Affordable Care Act (ACA), birth control and certain other preventive services are offered without co-payments or deductibles. A number of private firms focus on reducing unintended pregnancies and abortion related expenses; besides, the government also provides grants for IUCD products in order to encourage the usage of intrauterine contraceptive devices.
IUCD is safe and more effective than other contraceptives, such as oral contraceptives, as other contraceptives have several side effects, such as dizziness, headache, lightheadedness, stomach upset, bloating, or nausea.
This market is segmented and forecast on the basis of different types and products. The marketed products in the purview of this report are Mirena, Skyla, Paragard, Essure, and Livosert (a pipeline product). The market is further segmented and forecast on the basis of major countries, such as the U.S. and Canada.
This report also includes the market share, value chain analyses, usage percentage, and sales of different products, market metrics such as drivers, restraints, and upcoming opportunities in the market. In addition, it presents a competitive landscape and company profiles of key players in the market.
About MicroMarket Monitor:
MicroMarket Monitor identifies and attends to various unmet needs of different industrial verticals, which include value chain impact analysis. The company publishes about 12000 Market Research Reports on various Micro Markets across the world. The graphical nature and multidimensional analysis of these reports provide advanced Business Intelligence Tools to the clients in that particular target market.
Contact:
Mr. Chandrasekhar K.
UNIT no 802, Tower No. 7, SEZ
Magarpatta City, Hadapsar
Pune, Maharashtra 411013,
India
Tel: +1-888-502-0539
Email: sales@micromarketmonitor.com
